首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro
【24h】

Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro

机译:蟾蜍灵在体外抑制耐吉非替尼的NCI-H460人肺癌细胞迁移和侵袭

获取原文
获取原文并翻译 | 示例
           

摘要

Ethnopharmacological relevance: Bufalin, a component of Chan Su (frog), has been shown to have biological activities including anti-tumor effects. Gefitinib has been used as an anti-cancer drug in lung cancer patients; however, some patients eventually become gefitinib resistant.
机译:人类药理学相关性:蟾蜍灵是Chan Su(青蛙)的成分,已被证明具有生物活性,包括抗肿瘤作用。吉非替尼已被用作肺癌患者的抗癌药物;但是,有些患者最终对吉非替尼耐药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号